Skip to main content

Your search for “Targeted Delivery” returned 134 results

Students Propose Solutions to Critical Health Issues at Annual Hackathon

March 23, 2017

From virtual reality to crowdsourcing ideas, participants at UC Health Hack 2017 combined creativity and problem-solving to create projects addressing critical issues in health systems and global health. The 181 participants focused on one of two tracks: health care delivery or refugee health.

Health Care and Construction Workers Create Pink Ribbon For Breast Cancer Awareness

September 30, 2014

More than 600 health care and construction workers donned pink hard hats while forming a giant human ribbon at the UC San Diego Jacobs Medical Center construction site today in support of National Breast Cancer Awareness month.

Good Vibrations: Using Light-Heated Water to Deliver Drugs

April 1, 2014

Researchers from the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with materials scientists, engineers and neurobiologists, have discovered a new mechanism for using light to activate drug-delivering nanoparticles and other targeted therapeutic substances inside the body.

New CRISPR-based Gene-Drive System in Bacteria Defeats Antibiotic Resistance

December 16, 2019

Scientists have developed a CRISPR-based gene-drive system that inactivates a gene rendering bacteria antibiotic-resistant. The new system leverages technology developed by UC San Diego biologists in insects and mammals that biases genetic inheritance of preferred traits called “active genetics.”

UC San Diego and GSK Collaborate to Eradicate Cancer Stem Cells, Treat Leukemia

July 8, 2015

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center are working with GSK on a bench-to-bedside project to treat leukemia and other diseases by eliminating cancer stem cells. The collaboration is part of GSK’s Discovery Partnerships with Academia (DPAc) program, where academic partners become…

Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes

December 5, 2024

The first comprehensive map of the dramatic changes that take place in the blood system over the course of the human lifetime could have implications for the treatment of acute myeloid leukemia and other blood diseases.

Engineering Graduate Students Awarded Siebel Scholarship

September 20, 2024

Five UC San Diego graduate students applying engineering principles to solve medical challenges have been selected as 2025 Siebel Scholars. The Siebel Scholars program recognizes the most talented students in the world’s leading graduate schools of business, computer science, bioengineering and energy science.

Electric Fields Remove Nanoparticles From Blood With Ease

November 20, 2015

Engineers at the University of California, San Diego developed a new technology that uses an oscillating electric field to easily and quickly isolate drug-delivery nanoparticles from blood. The technology could serve as a general tool to separate and recover nanoparticles from other complex fluids for medical, environmental, and industrial applications.

UC San Diego Cancer Researchers Receive $4 Million CIRM Disease-Team Grant

December 13, 2013

Researcher Thomas J. Kipps, MD, PhD, professor of medicine and deputy director of research operations at UC San Diego Moores Cancer Center, is principal investigator for one of six “Disease Team” awards approved December 12 by the governing board of the California Institute for Regenerative Medicine (CIRM).

UC San Diego Nanoengineer Selected as the U.S. Nominee for 2017 ASPIRE Prize

April 25, 2017

Nanoengineering professor Liangfang Zhang at the University of California San Diego has been selected as the U.S. nominee for the APEC Science Prize for Innovation, Research and Education (ASPIRE). Zhang won the nomination for his revolutionary work in the field of nanomedicine, which focuses on nanomaterials for medical applications.

Category navigation with Social links